Andere talen Galera Therapeutics, Inc.

Aandelen

GRTX

US36338D1081

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1827 ^USD	-5,82%		-7,91%	+25,65%

28/03	Galera Therapeutics, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
28/03	Galera Therapeutics, Inc. Rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North American Morning Briefing : Powell Awaited -2-	03/04
Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates	28/03
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	27/03
North American Morning Briefing : Markets on Hold -2-	20/03
North American Morning Briefing : Stock Futures -2-	13/03
Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Therapeutics Announces Review of Strategic Alternatives	31-10-23
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial	31-10-23
Galera Therapeutics, Inc. Announces Receipt of Type A Meeting Minutes and Strategic Update	31-10-23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31-10-23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31-10-23
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	22-09-23
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem	18-09-23
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	05-09-23
North American Morning Briefing : Treasury Yields -2-	17-08-23
Galera Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Galera Therapeutics, Inc.

Aandelen

GRTX

US36338D1081

Andere talen

Filters